Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion
Walker U, Courvoisier D, Dudler J, Aeberli D, von Kempis J, Scherer A, Finckh A, Swiss Clinical Quality Management Programme in Rheumatic Diseases. Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion. Rheumatology (Oxford) 2010; 50:243-4.
17.08.2010
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion
17.08.2010
Rheumatology (Oxford) 2010; 50:243-4
Walker Ulrich A, Courvoisier Delphine S, Dudler Jean, Aeberli Daniel, von Kempis Johannes, Scherer Almut, Finckh Axel, Swiss Clinical Quality Management Programme in Rheumatic Diseases
Weiter
